ES8105145A1 - Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal - Google Patents
Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animalInfo
- Publication number
- ES8105145A1 ES8105145A1 ES491307A ES491307A ES8105145A1 ES 8105145 A1 ES8105145 A1 ES 8105145A1 ES 491307 A ES491307 A ES 491307A ES 491307 A ES491307 A ES 491307A ES 8105145 A1 ES8105145 A1 ES 8105145A1
- Authority
- ES
- Spain
- Prior art keywords
- hydroxyalkyl
- drug carrier
- starch
- starch drug
- active compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/14—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/05—Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur
- C08B15/06—Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur containing nitrogen, e.g. carbamates
Abstract
PROCEDIMIENTO DE OBTENCION DE UNA COMPOSICION CONTROLADA DE UN COMPUESTO BIOLOGICAMENTE ACTIVO. CONSISTE EN HACER REACCIONAR EL COMPONENTE BIOLOGICO ACTIVO CON EL POLIMERO PARA FORMAR UN ENLACE ENTRE AMBOS; DICHO ENLACE ES UN ENLACE LABIL QUE ES SOMETIDO A INCISION <<IN VITRO>>. EL COMPUESTO BIOLOGICAMENTE ACTIVO MANTIENE SU ACTIVIDAD BIOLOGICA <<IN VIVO>> MIENTRAS ESTA UNIDO AL HIDROXIALQUIL-ALMIDON A TRAVES DE UN DERIVADO. EL HIDROXIETIL-ALMIDON PRESENTA UN GRADO DE SUSTITUCION DE 0,1 A 1, SIENDO SU PESO MOLECULAR DE 10.000 A 2.000.000, APROXIMADAMENTE. EL COMPUESTO BIOLOGICAMENTE ACTIVO ES HIERRO. LA COMPOSICION CONTIENE ADEMAS ACIDO CITRICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3798179A | 1979-05-10 | 1979-05-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES491307A0 ES491307A0 (es) | 1981-05-16 |
ES8105145A1 true ES8105145A1 (es) | 1981-05-16 |
Family
ID=21897414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES491307A Expired ES8105145A1 (es) | 1979-05-10 | 1980-05-08 | Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP0019403B1 (es) |
JP (1) | JPH0140812B2 (es) |
KR (1) | KR840001798B1 (es) |
AT (1) | ATE12892T1 (es) |
CA (1) | CA1158159A (es) |
DE (1) | DE3070546D1 (es) |
DK (1) | DK155078C (es) |
ES (1) | ES8105145A1 (es) |
NZ (1) | NZ193618A (es) |
WO (1) | WO1980002374A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045135A1 (de) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
DE3421954C1 (de) * | 1984-06-13 | 1985-10-24 | Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen | Diätetisches Nährmittel, enthaltend Hydroxyethylstärke |
DK110188D0 (da) * | 1988-03-02 | 1988-03-02 | Claus Selch Larsen | High molecular weight prodrug derivatives of antiinflammatory drugs |
US5830884A (en) * | 1995-01-18 | 1998-11-03 | National Starch And Chemical Investment Holding Corporation | Pharmaceutical products containing thermally-inhibited starches |
DE10112825A1 (de) | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
DE10209821A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
DE10209822A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
EP1400533A1 (en) * | 2002-09-11 | 2004-03-24 | Fresenius Kabi Deutschland GmbH | HASylated polypeptides, especially HASylated erythropoietin |
WO2004024776A1 (en) * | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | Method of producing hydroxyalkyl starch derivatives |
AU2003273413A1 (en) | 2002-10-08 | 2004-05-04 | Fresenius Kabi Deutschland Gmbh | Pharmaceutically active oligosaccharide conjugates |
DE10256558A1 (de) * | 2002-12-04 | 2004-09-16 | Supramol Parenteral Colloids Gmbh | Ester von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe |
WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
WO2005092928A1 (en) | 2004-03-11 | 2005-10-06 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
EP2070950A1 (en) | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives and process for their preparation |
GB0811743D0 (en) | 2008-06-26 | 2008-07-30 | Hemosol Biopharma Inc | Composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1167794B (de) * | 1953-09-03 | 1964-04-16 | Corn Products Company Eine Ges | Verfahren zum Einbetten wasserunloeslicher Vitamine und anderer bei der Aufbewahrung sich verschlechternder oder verdampfender Stoffe in eine Umhuellung |
US3523938A (en) | 1967-12-13 | 1970-08-11 | American Hospital Supply Corp | Starch plasma expanders and process of preparation |
US3908004A (en) * | 1970-05-20 | 1975-09-23 | C L Basingstoke Limited | Process for making injectable iron compositions for treating iron-deficiency anemia |
US3928581A (en) * | 1972-09-13 | 1975-12-23 | Astra Laekemedel Ab | Certain polymer-iron complexes for treatment of iron deficiency |
DE2500076C3 (de) * | 1975-01-02 | 1982-11-18 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen |
US4026986A (en) * | 1975-05-22 | 1977-05-31 | The Dow Chemical Company | Capsule shell |
US4180567A (en) * | 1977-09-02 | 1979-12-25 | Pharmachem Corporation | Iron preparations and methods of making and administering the same |
DE2829037A1 (de) * | 1978-07-01 | 1980-01-10 | Fresenius Chem Pharm Ind | Wasserloesliche, keimtoetende mittel enthaltende mund- und rachenpflegemittel |
DE2838736A1 (de) * | 1978-09-06 | 1980-03-20 | Theodor Prof Dr Eckert | Verwendung von hydroxyaethylstaerke als pudergrundlage |
JPS6348545A (ja) * | 1986-08-18 | 1988-03-01 | Nippon Zeon Co Ltd | 感光性フレキソ版用エラストマ−組成物 |
-
1980
- 1980-05-02 EP EP80301464A patent/EP0019403B1/en not_active Expired
- 1980-05-05 NZ NZ193618A patent/NZ193618A/en unknown
- 1980-05-08 ES ES491307A patent/ES8105145A1/es not_active Expired
- 1980-05-08 JP JP55501330A patent/JPH0140812B2/ja not_active Expired
- 1980-05-08 DE DE8080901128T patent/DE3070546D1/de not_active Expired
- 1980-05-08 AT AT80901128T patent/ATE12892T1/de active
- 1980-05-08 WO PCT/US1980/000527 patent/WO1980002374A1/en active IP Right Grant
- 1980-05-09 CA CA000351586A patent/CA1158159A/en not_active Expired
- 1980-05-10 KR KR1019800001857A patent/KR840001798B1/ko active
- 1980-11-17 EP EP80901128A patent/EP0028641B1/en not_active Expired
-
1981
- 1981-01-07 DK DK004481A patent/DK155078C/da active
Also Published As
Publication number | Publication date |
---|---|
WO1980002374A1 (en) | 1980-11-13 |
EP0019403B1 (en) | 1985-07-31 |
KR840001798B1 (ko) | 1984-10-20 |
ES491307A0 (es) | 1981-05-16 |
CA1158159A (en) | 1983-12-06 |
NZ193618A (en) | 1984-07-06 |
KR830002510A (ko) | 1983-05-30 |
JPH0140812B2 (es) | 1989-08-31 |
EP0028641B1 (en) | 1985-04-24 |
ATE12892T1 (de) | 1985-05-15 |
DE3070546D1 (de) | 1985-06-05 |
EP0028641A1 (en) | 1981-05-20 |
DK4481A (da) | 1981-01-07 |
DK155078C (da) | 1989-07-10 |
EP0019403A3 (en) | 1981-10-07 |
EP0019403A2 (en) | 1980-11-26 |
EP0028641A4 (en) | 1981-09-01 |
JPS56500495A (es) | 1981-04-16 |
DK155078B (da) | 1989-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY101544A (en) | Pharmaceutical composition for external use containing active-type vitamin d3. | |
ES8105145A1 (es) | Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal | |
GR860060B (en) | Slow release solid preparation | |
DE3070407D1 (en) | System for demand-based administration of insulin | |
GB2046209B (en) | Encapsulation of chemically active biologically active materials and viable tissue | |
EP0032927A4 (en) | SYSTEM FOR CONTROLLED RELEASE OF A BIOLOGICALLY ACTIVE SUBSTANCE IN A BODY LIQUID. | |
ES8702153A1 (es) | Un metodo de administracion de una cantidad terapeuticamenteefectiva de timolol | |
EG18379A (en) | Novel pharmacological compounds | |
ES8402720A1 (es) | Procedimiento para la obtencion de una composicion a base de estireno para revestir alimentos y medicamentos. | |
ES478967A1 (es) | Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7. | |
IL52936A (en) | Coating ensuring a controlled release of active ingredients of biologically active compositions,particularly pharmaceutical compositions,its production and preparations having such a coating | |
GB1390803A (en) | Medicinal tampons and compositions containing lactulose | |
IL54501A (en) | N-(trifluoromethanesulphonamidophenyl)-n-heterocyclic compounds,their preparation and their use for regulation of plant growth | |
IL57847A (en) | Adducts of k vitaminic compounds with therapeutically active stabilizers,preparation thereof and animal feeds containing them | |
ATE68686T1 (de) | System zum freigeben von stoffen in der vagina. | |
DE3874610D1 (es) | ||
CH611132A5 (en) | Preparation for the controlled release of an effective amount of a biologically active material to the environment, and use of this preparation | |
ES458756A1 (es) | Procedimiento para preparar derivados de isotiourea. | |
ES8504665A1 (es) | Metodo de preparar derivados de p-acilaminofenol | |
JPS5531096A (en) | Novel compound bissindoline derivative active as drug and its manufacture | |
JPS53127432A (en) | Novel physiologically active substance, anthglutin, and its preparation | |
HUT41962A (en) | Insecticides containing as active substance derivatives of piretroid | |
NZ192119A (en) | Perhydro-1,3-thiazine derivatives pharmaceutical and veterinary compostions | |
UA18587A (uk) | Спосіб одержаhhя макролідhих сполук | |
PH12226A (en) | Derivatives of 1,2,4-triazole for combatting various animal and plant pests |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970203 |